Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puhakainen, I.
Right arrow Articles by Yki-Jarvinen, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puhakainen, I.
Right arrow Articles by Yki-Jarvinen, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 17, Issue 8 805-809, Copyright © 1994 by American Diabetes Association


ARTICLES

Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM

I Puhakainen, MR Taskinen and H Yki-Jarvinen
Second Department of Medicine, University of Helsinki, Finland.

OBJECTIVE--The question of whether to use insulin in the evening or in the morning during combination therapy in patients with non-insulin-dependent diabetes mellitus (NIDDM) is controversial. We compared the acute effects of 12-h nocturnal or daytime insulin infusions on the 24-h glucose profile in 20 patients with NIDDM. RESEARCH DESIGN AND METHODS--NIDDM patients were 56 +/- 2 (mean +/- SE) years of age and had a body mass index of 29.6 +/- 1.1 kg/m2; fasting plasma glucose concentration of 12.2 +/- 0.5 mM; and fasting C-peptide concentration of 0.9 +/- 0.2 nM. Each patient was studied twice. On one occasion, the patient received a 12-h intravenous infusion of insulin (mean 1.5 +/- 0.1 IU/h) during the day, and on the other occasion an identical dose of insulin was infused during the night. Blood glucose, insulin, c-peptide, and free fatty acid concentrations were determined for 24 h. RESULTS--The mean 24-h free insulin concentrations were similar in both studies (150 +/- 12 vs. 162 +/- 12 pM, daytime versus nocturnal insulin infusion). The mean 24-h free fatty acid concentration was 18% lower in the nocturnal than in the daytime (309 +/- 30 vs. 376 +/- 30 microM, P < 0.001) insulin infusion study. The mean 24-h C-peptide concentration was less suppressed if insulin was infused overnight than during the day (1.3 +/- 0.2 vs. 1.1 +/- 0.2 nM, P < 0.01). The mean 24-h plasma glucose concentrations were identical in both studies (11.1 +/- 0.6 vs. 11.4 +/- 0.7 mM, daytime versus nocturnal insulin infusion). We also searched for factors predicting the decrease in the blood glucose concentration during the nocturnal insulin infusion. The best predictors were a high initial blood glucose concentration at 2200 and a low fasting C-peptide concentration. These factors explained, independent of each other, 50% of the rate of decrease in the plasma glucose concentration. CONCLUSIONS--Despite better suppression of lipolysis and less suppression of endogenous insulin secretion by nocturnal than daytime insulinization, the hypoglycemic effect of these two treatments is similar.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.